Featured Research

from universities, journals, and other organizations

Nanoparticle vaccine protects against stomach flu

Date:
January 20, 2011
Source:
American Society for Microbiology
Summary:
A new vaccine strategy using nanoparticles as carriers may be the key to developing a vaccine against norovirus, one of the most common causes of foodborne disease in the United States.

A new vaccine strategy using nanoparticles as carriers may be the key to developing a vaccine against norovirus, one of the most common causes of foodborne disease in the United States. Researchers from the Cincinnati Children's Hospital Medical Center report promising findings in the January 2011 issue of the Journal of Virology.

The application of nanoparticles as carriers to present small peptide antigens is a growing field within vaccine development. Researchers led by Xi Jason Jiang of Cincinnati Children's Hospital Medical Center, have described a new nanocarrier, called a P particle, which holds promise as a scaffold for a variety of vaccines. In the current study they inserted rotavirus antigen into the P particle, which boosted immune response to rotavirus, as well as norovirus, in mice.

Both rotavirus and norovirus are important causes of acute gastroenteritis. The former causes severe diarrhea in children, and kills an estimated 527,000 worldwide, annually. Norovirus is a notably highly transmissible, and particularly unpleasant flu, which can result in one to three days of vomiting and diarrhea in otherwise healthy adults, and which kills 200,000 children annually.

"The dual vaccine holds promise for controlling gastroenteritis in children," says Jiang.

The P particle's unique feature is the scaffold. The P particle consists of 24 copies of an outer coat protein from norovirus. The beauty of the P particle is that it contains three types of surface loops, which are ideal for presenting a wide variety of antigens. Additionally, it is highly immunogenic and extremely stable, the latter an important quality for use in developing nations. The antigens can easily be inserted during the manufacturing process. Production is a simple matter of expressing the cloned P particle in E. coli.

In addition to the rotavirus antigen, the team has succeeded in inserting a number of antigens into the P particle, varying in size up to more than 200 amino acids. The resulting vaccines have induced significantly stronger immune responses in mice than have free antigens.

Jiang is principal investigator for a five year, $4.1 million grant from the National Institute of Allergy & Infectious Disease (NIAID) that Cincinnati Children's received last May to develop the P particle vaccine against norovirus. "With the unique features of high efficiency, easy production, and low cost, this new platform will find a broad application in the biomedical sciences," says Jiang.


Story Source:

The above story is based on materials provided by American Society for Microbiology. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. Tan, P. Huang, M. Xia, P.-A. Fang, W. Zhong, M. McNeal, C. Wei, W. Jiang, X. Jiang. Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production. Journal of Virology, 2010; 85 (2): 753 DOI: 10.1128/JVI.01835-10

Cite This Page:

American Society for Microbiology. "Nanoparticle vaccine protects against stomach flu." ScienceDaily. ScienceDaily, 20 January 2011. <www.sciencedaily.com/releases/2011/01/110119191230.htm>.
American Society for Microbiology. (2011, January 20). Nanoparticle vaccine protects against stomach flu. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2011/01/110119191230.htm
American Society for Microbiology. "Nanoparticle vaccine protects against stomach flu." ScienceDaily. www.sciencedaily.com/releases/2011/01/110119191230.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins